<DOC>
	<DOC>NCT02790060</DOC>
	<brief_summary>Subjects with type 1 diabetes are invited to provide usual blood glucose monitoring and a blood glucose profile (Pre/ post prandial Blood Glucose + Night Blood Glucose) on 3 occasions in a 2 week time period, in addition to the filling of 5 questionnaires including fear of hypoglycemia-2 questionnaire.</brief_summary>
	<brief_title>Fear of Hypoglycemia and Glycemic Variability</brief_title>
	<detailed_description>Subjects with type 1 diabetes are invited to provide usual blood glucose monitoring and a blood glucose profile (Pre/ post prandial Blood Glucose + Night Blood Glucose) on 3 occasions in a 2 week time period, in addition to the filling of questionnaires including fear of hypoglycemia-2 questionnaire. Biobanking of urine/blood Collection of key medical informations by investigators Questionnaires : - socio-economic status - Fear of hypoglycemia-2 - Anxiety Depression scale (HAD) - Health survey (SF36, SF12) - Satisfaction to treatment (DHP-18) - Dutch Eating Behavior Questionnaire (DEBQ) - Pittsburgh quality of sleep (PSQI) - Blood Glucose diary</detailed_description>
	<criteria>Inclusion Criteria : type 1 diabetes at least 2 Blood Glucose monitoring daily on insulin for more than 5 years Exclusion Criteria : not stable metabolic condition (infection, steroid therapy) below 3 months change in insulin treatment other clinical trial renal failure (eDFG below 30 ml/min/1.73 mÂ²) Pregnancy and/or lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>diabetes</keyword>
</DOC>